Nanocarriers represent a groundbreaking paradigm in drug delivery, offering a multifaceted approach to address the challenges of conventional therapeutic interventions. These nano-sized vehicles, typically ranging from 1 to 1000 nanometers, serve as sophisticated carriers for drugs, enabling targeted and controlled delivery to specific sites within the body. One of the key advantages of nanocarriers is their capacity to encapsulate diverse therapeutic agents, including small molecules, proteins, and genetic materials. This versatility opens avenues for precision medicine by tailoring drug delivery strategies to individual patient needs. Nanocarriers enhance drug stability, enabling sustained release and protecting encapsulated drugs from degradation.
In addition to their role in improving drug bioavailability, nanocarriers contribute to minimizing off-target effects and enhancing therapeutic efficacy. Their small size allows for efficient drug penetration into tissues and cells, ensuring a more profound impact on the intended target. Ongoing research in nanocarrier technology focuses on refining their design, surface modification, and functionalization, paving the way for personalized and targeted drug delivery in diverse therapeutic applications.
Thomas J Webster
Hebei University of Technology, United States
Hossein Hosseinkhani
Innovation Center for Advanced Technology, Matrix, Inc., United States
Hai Feng Ji
Drexel University, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Azzedine Bensalem
Long Island University, United States
Robert Buenker
Wuppertal University, Germany
Rafal Kozubski
Jagiellonian University in Krakow, Poland
Sylwia Wcislik
Kielce University of Technology, Poland
Raman Singh
Monash University-Clayton Campus, Australia
Michael I Tribelsky
Moscow State University, Russian FederationSubmit your abstract Today
Title : Circumventing challenges in developing CVD graphene coating on mild steel: A disruptive approach to remarkable/durable corrosion resistance
Raman Singh, Monash University-Clayton Campus, Australia
Title : Highlighting recent advancements in electromagnetic field subwavelength tailoring using nanoparticle resonant light scattering and related topics
Michael I Tribelsky, Moscow State University, Russian Federation
Title : The impact of nanomedicine: 30,000 orthopedic nano implants with no failures and still counting
Thomas J Webster, Hebei University of Technology, United States
Title : Logistic-modified mathematical model for tumor growth treated with nanosized cargo delivery system
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Current and future of red and black phosphorus nanomaterials
Hai Feng Ji, Drexel University, United States
Title : Azodye photoaligned nanolayers for liquid crystal: New trends
Vladimir G Chigrinov, Hong Kong University of Science and Technology, Hong Kong
Title : Atomistic simulation of chemical ordering phenomena in nanostructured intermetallics
Rafal Kozubski, Jagiellonian University in Krakow, Poland
Title : The enhanced cytotoxic effect of curcumin on leukemic stem cells via CD123-targeted nanoparticles
Wariya Nirachonkul, Chiang Mai University, Thailand
Title : Efficiency of nanoparticles (Micromage-B) in the complex treatment of multiple sclerosis
Andrey Belousov, Kharkiv National Medical University, Ukraine
Title : Innovative method of nanotechnology application in the complex treatment of multiple sclerosis
Andrey Belousov, Kharkiv National Medical University, Ukraine